乙肝临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 乙肝（国际通用名 hepatitis B）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖乙型肝炎、慢性乙肝等说法。

正在招募的乙肝新药试验

• Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Women

  IV 期招募中CameroonNCT05403047

• Real-world Study Optimizing Nucleotide-analogues

  不适用招募中中国NCT05937178

• Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.

  不适用招募中中国NCT04231565

• Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer

  不适用招募中英国NCT06658782

• Adaptability of an Undetectable = Untransmissible Model for HBV

  不适用招募中美国NCT07449091

• Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection

  I 期招募中Denmark德国NCT07610772

• A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma

  I 期 / II 期招募中美国中国香港SingaporeNCT05417932

• A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B

  II 期招募中中国NCT06263959

• Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients

  不适用招募中中国NCT05988879

• Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study)

  I 期招募中DenmarkNCT06668727

• HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients

  I 期招募中中国NCT06885710

• Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions

  II 期招募中美国加拿大法国意大利NCT07654283